INNATE PHARMA EUR0.05

The current price of 0EVI is 2.245 EUR — it has increased by 1.82% in the past 24 hours.

Depending on the exchange, the stock ticker may vary. For instance, on LSIN exchange INNATE PHARMA EUR0.05 stocks are traded under the ticker 0EVI.

INNATE PHARMA EUR0.05 is going to release the next earnings report on Sep 12, 2024. Keep track of upcoming events with our Earnings Calendar.

0EVI stock is 1.79% volatile and has beta coefficient of 0.56. Check out the list of the most volatile stocks — is INNATE PHARMA EUR0.05 there?

0EVI earnings for the last quarter are 0.02 EUR per share, whereas the estimation was 0.08 EUR resulting in a −75.00% surprise. The estimated earnings for the next quarter are −0.40 EUR per share. See more details about INNATE PHARMA EUR0.05 earnings.

INNATE PHARMA EUR0.05 revenue for the last quarter amounts to ‪40.20 M‬ EUR despite the estimated figure of ‪63.88 M‬ EUR. In the next quarter revenue is expected to reach ‪16.82 M‬ EUR.

Yes, you can track INNATE PHARMA EUR0.05 financials in yearly and quarterly reports right on TradingView.

0EVI stock has risen by 5.90% compared to the previous week, the month change is a 2.63% rise, over the last year INNATE PHARMA EUR0.05 has showed a 13.81% decrease.

Today INNATE PHARMA EUR0.05 has the market capitalization of ‪181.49 M‬, it has decreased by 1.59% over the last week.

No, 0EVI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.

Like other stocks, 0EVI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INNATE PHARMA EUR0.05 stock right from TradingView charts — choose your broker and connect to your account.

0EVI reached its all-time high on Apr 27, 2015 with the price of 17.230 EUR, and its all-time low was 1.995 EUR and was reached on Nov 10, 2022.
See other stocks reaching their highest and lowest prices.

As of Apr 28, 2024, the company has 179.00 employees. See our rating of the largest employees — is INNATE PHARMA EUR0.05 on this list?

Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INNATE PHARMA EUR0.05 technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INNATE PHARMA EUR0.05 stock shows the sell signal. See more of INNATE PHARMA EUR0.05 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.

We've gathered analysts' opinions on INNATE PHARMA EUR0.05 future price: according to them, 0EVI price has a max estimate of 10.69 EUR and a min estimate of 2.25 EUR. Read a more detailed INNATE PHARMA EUR0.05 forecast: see what analysts think of INNATE PHARMA EUR0.05 and suggest that you do with its stocks.

EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INNATE PHARMA EUR0.05 EBITDA is ‪−17.32 M‬ EUR, and current EBITDA margin is −33.36%. See more stats in INNATE PHARMA EUR0.05 financial statements.